![Sasha Austin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sasha Austin
Comptroller/Controller/Auditor chez
OLEMA PHARMACEUTICALS, INC.
Fortune : 168 841 $ au 31/08/2026
Profil
Ms. Sasha Austin, CPA, is a Vice President-Finance & Controller at Olema Pharmaceuticals, Inc. and a Member at The American Institute of Certified Public Accountants.
Ms. Austin was previously employed as a Controller by GigCapital Global Corp.
She received her undergraduate degree from Seattle University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/02/2026 | 16 188 ( 0,02 % ) | 168 841 $ | 31/08/2026 |
Postes actifs de Sasha Austin
| Sociétés | Poste | Début |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/04/2023 |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
Anciens postes connus de Sasha Austin
| Sociétés | Poste | Fin |
|---|
Formation de Sasha Austin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
73
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
Seattle University
 Seattle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Olema Pharmaceuticals, Inc.
 Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
